Why Harmony Biosciences (HRMY) Stock Is Down 18% Today
Why Harmony Biosciences (HRMY) Stock Is Down 18% Today
Additionally, a lock-up agreement restricts the sale of additional shares by key company insiders for 60 to 90 days.Harmony Biosciences Holdings Inc (NASDAQ:HRMY) shares are trading lower by 18.3% to $33.89 Wednesday afternoon after the company announced a public offering of up to 8 million shares of common stock by selling shareholders Marshman Fund Trust II and Valor IV Pharma Holdings.
Harmony Biosciences控股公司（纳斯达克：HRMY）的股价周三下跌了18.3％，至33.89美元，因为公司宣布将发行多达800万股普通股的公开要约，由出售股东Marshman Fund Trust II和Valor IV Pharma Holdings负责。
What Else: Harmony Biosciences is offering 8 million shares of common stock through selling shareholders, who have granted underwriters a 30-day option to buy up to an additional 1.2 million shares.
此外，Harmony Biosciences通过出售股东提供了800万股普通股，这些股东已授予承销商购买多达额外120万股的权利。
The offering will not increase the company's outstanding share count, which will remain at 57,030,897 shares. Harmony will not receive any proceeds from this sale; all net proceeds go directly to the selling shareholders.
此次发行不会增加公司的流通股数量，其将保持在57,030,897股。Harmony将不会从这次销售中获得任何收益；所有净收益直接归销售股东所有。
Additionally, a lock-up agreement restricts the sale of additional shares by key company insiders for 60 to 90 days.
此外，一项锁定协议限制了关键公司内部人士在60至90天内出售额外股份。
Read Also: Wall Street Mixed, Semiconductors Tumble As AMD Disappoints, Alphabet Rallies, SMCI Plummets: What's Driving Markets Wednesday?
阅读更多：华尔街走势混杂，半导体下跌，AMD令人失望，Alphabet反弹，SMCI暴跌：周三市场的推动因素是什么？
According to data from Benzinga Pro, HMRY has a 52-week high of $41.61 and a 52-week low of $22.03.
根据Benzinga Pro的数据，HMRY的52周最高价为41.61美元，52周最低价为22.03美元。
